Structure–activity relationship of piperine
expression of XBP1 and JNK (downstream targets of IRE1
arm) would help to unravel the mechanism(s) behind its pro-
tective effects against ER stress. Our studies with piperine in a
model of DTT-induced ER stress in NRK-52E cells recapitu-
lated the findings obtained from the model of tunicamycin-
induced ER stress on GRP78 and CHOP expression (shown in
ESM 2). Consistent with our findings, topical application of
piperine and its cyclohexylamino analog for 4 weeks was
shown to ameliorate vitiligo (Faas et al. 2008), a condition
that is strongly associated with ER stress (Jeong et al. 2010;
Toosi et al. 2012). Together, these findings indicate the thera-
peutic potential of piperine and its cyclohexylamino analog to
act as Bchemical chaperones^ under the conditions of ER
stress.
Unlike piperine, piperic acid (PA1) did not affect the ex-
pression of CHOP and GRP78. Intriguingly, treatment with
diethylamino analog (PA3) caused a paradoxical increase in
the expression of CHOP in renal cells. Thus, further studies
are required to understand their impact on the CHOP expres-
sion and to determine whether its effects on CHOP are tran-
sient or permanent. Although treatment with pyrrolidinyl an-
alog (PA4) did not alter the induction of ER stress markers
GRP78 and CHOP in renal cells, it showed improvements in
cell viability against tunicamycin-induced cytotoxicity.
Our studies to unravel the mechanisms underlying the
chemical chaperone activity and cytoprotective effects of pip-
erine indicate that pre-treatment with piperine decreases the
induction of ER-associated caspase-12 and the executioner
caspase-3 in renal cells subjected to tunicamycin. Although
studies in cancer lines (Lin et al. 2013; Samykutty et al. 2013;
Yaffe et al. 2015) have demonstrated piperine’s ability to in-
duce apoptosis especially at high concentrations (in micromo-
lar range), to our knowledge, this is the first study to demon-
strate the anti-apoptotic effects of piperine (at nanomolar con-
centrations) in normal cells. The discrepancy in the pro-
apoptotic vs. anti-apoptotic effects of piperine could be attrib-
uted to the neoplastic state of the cells (cancerous vs. non-
cancerous) and the dose tested, i.e., anti-apoptotic at low
(nanomolar) concentrations and pro-apoptotic at high
(micromolar) concentrations.
increase in CHOP expression, which might aggravate
ER stress.
4. Removal of the piperidine ring by hydrolysis of piperine
(PIP) or replacement of six-membered ring with a five-
membered ring (pyrrolidinyl analog (PA4)) appears to re-
sult in loss of pharmacological activity against ER stress.
5. CompoundsPIP,PA2,andPA4alsopossesscytoprotective
properties against ER stress-induced cell death.
6. In terms of potency, piperine and its analogs (used in
nanomolar concentrations) are about 4000 times more
potent when compared to the reference standard 4PBA
(used in millimolar concentration).
In conclusion, considering their high potency (used in nM),
efficacy, and a wide margin of safety, piperine (PIP) and its
cyclohexylamino analog (PA2) appear to be promising drug
candidates for further investigation in vivo for prevention of
ER stress and potential application to treat ER stress-related
renal disorders in patients.
Acknowledgments This study was supported by the intramural grants
(QUUG-CPH-CPH-13/14-2; QUST-CPH-SPR-12/13-5; QUSTCPH-
FALL-13/14-6; QUST-CPH-SPR-13/14-8; QUST-CPH-FALL-14/15-5;
QUST-CPH-SPR-14/15-14) awarded by the Office of Academic
Research, Qatar University, Doha, Qatar.
References
Brandizzi F, Frigerio L, Howell SH, Schafer P (2014) Endoplasmic
reticulum-shape and function in stress translation. Front Plant Sci
Carlisle RE, Brimble E, Werner KE, Cruz GL, Ask K, Ingram AJ,
Dickhout JG (2014) 4-Phenylbutyrate inhibits tunicamycin-
induced acute kidney injury via CHOP/GADD153 repression.
Cybulsky AV, Takano T, Papillon J, Bijian K (2005) Role of the endo-
plasmic reticulum unfolded protein response in glomerular epithelial
Cybulsky AV, Takano T, Papillon J, Bijian K, Guillemette J, Kennedy CR
(2009) Glomerular epithelial cell injury associated with mutant al-
pha-actinin-4. American journal of physiology renal physiology
Doucette CD, Greenshields AL, Liwski RS, Hoskin DW (2015) Piperine
blocks interleukin-2-driven cell cycle progression in CTLL-2 T lym-
phocytes by inhibiting multiple signal transduction pathways.
Drawz P, Hostetter TH, Rosenberg ME (2015) Chapter 49—slowing
progression of chronic kidney disease. In: Kimmel PL, Rosenberg
ME (eds) Chronic renal disease. Academic Press, San Diego, pp
Faas L, Venkatasamy R, Hider RC, Young AR, Soumyanath A (2008)
In vivo evaluation of piperine and synthetic analogues as potential
treatments for vitiligo using a sparsely pigmented mouse model. Br J
Further studies with different side chains and amine sub-
stituents in the aromatic moiety are required to elucidate the
structure–activity relationship (Ferreira et al. 2011) of these
compounds. Nevertheless, based on our research findings,
we were able to identify and propose the following.
1. Piperine and its analogs are pharmacologically active at
nanomolar (nM) concentrations.
2. Similar to 4PBA, piperine (PIP) and its cyclohexylamino
analog (PA2) can decrease the expression of GRP78 and
CHOP in renal cells and attenuate ER stress.
3. Opening of piperidine ring structure in piperine
(diethylamino analog (PA3)) causes a paradoxical